Results 51 to 60 of about 2,368,347 (279)

Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma:retrospective review

open access: yesInternational Journal of Ophthalmology, 2014
AIM:To evaluate the outcomes of trabeculectomy with large area mitomycin-C (MMC) application as a first line treatment in advanced glaucoma.METHODS:The records of 55 patients with severe visual field defects undergoing trabeculectomy were retrospectively
Zeynep Aktas   +4 more
doaj   +1 more source

Functional Dynamics of Deafferented Early Visual Cortex in Glaucoma

open access: yesFrontiers in Neuroscience, 2021
In advanced retinitis pigmentosa with retinal lesions, the lesion projection zone (LPZ) in the early visual cortex can be driven during visual tasks, while it remains unresponsive during passive viewing.
Gokulraj T. Prabhakaran   +6 more
doaj   +1 more source

Advances in Glaucoma Surgery

open access: yesDelhi Journal of Ophthalmology, 2016
Currently popular glaucoma filtration surgeries which include trabeculectomy and glaucoma drainage devices have their share of vision-threatening complications. Lately less invasive and safer devices have been developed to be used alone or in conjunction with cataract surgery for lowering the intraocular pressure. These microscopic implants utilize the
Arushi Garg, Rishika Jain, Usha Yadava
openaire   +3 more sources

Comparison between control eyes, early glaucoma and advanced glaucoma.

open access: yes, 2019
Comparison between control eyes, early glaucoma and advanced glaucoma.
Alfonso Casado (697004)   +8 more
core   +1 more source

Multicenter Validation of Machine Learning Models for Predicting Myopia Progression Across School‐Based Screening and Optical Intervention Settings in Chinese Children and Adolescents

open access: yesAdvanced Intelligent Discovery, EarlyView.
Machine‐learning models predict myopia trajectories from 12 routine ocular variables in 40 445 children across 10 hospitals. Externally validated across school‐based screening and optical‐intervention settings, the best models achieve AUROC 0.97 for myopia status and R2 0.83 for spherical equivalent, enabling personalized risk stratification to curb ...
Yitong Zhang   +14 more
wiley   +1 more source

What Is New in Glaucoma: From Treatment to Biological Perspectives

open access: yesJournal of Ophthalmology, 2021
Glaucoma is a chronic silent disease and an irreversible cause of blindness worldwide. Research has made many efforts to improve disease control and especially to anticipate both early diagnosis and treatment of advanced stages of glaucoma.
Raffaele Nuzzi   +2 more
doaj   +1 more source

A cohort study of duplex Doppler examinations of the carotid artery in primary open angle glaucoma [PDF]

open access: yes, 2014
Objectives To explore the possibility of pathological change in the common carotid artery at the bifurcation and in the internal carotid artery beyond the bifurcation which could contribute to a reduced diastolic pressure as observed in primary open ...
Aldoori, M. I.   +7 more
core   +1 more source

Outcomes of iStent Inject Versus Kahook Dual Blade Surgery in Glaucoma Patients Undergoing Cataract Surgery

open access: yes, 2023
Précis: iStent Inject implantation (iStent) or Kahook Dual Blade goniotomy (KDB) in combination with phacoemulsification have a similar IOP-lowering effect in all stages of glaucoma, and medications are significantly reduced, especially after KDB ...
Gauti Jóhannesson   +8 more
core   +1 more source

Heterozygous Variants in LRP1 Cause a Neurodevelopmental Disorder With Congenital Heart Defects

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT LRP1 encodes the low‐density lipoprotein (LDL) receptor‐related protein 1 (LRP1), a transmembrane protein involved in endocytosis and activation of multiple signaling pathways. LRP1 variants have been implicated in the pathogenesis of congenital heart defects (CHD), Alzheimer's disease, and neurodevelopmental disorders (NDD).
Alyssa L. Rippert   +31 more
wiley   +1 more source

Translational Macrophage Mechano‐Immunotherapy for Next‐Generation Implantable Biomaterials

open access: yesAdvanced NanoBiomed Research, EarlyView.
This review explores how macrophage mechanosensing drives inflammation, fibrosis and foreign body responses to implanted biomaterials. It examines emerging pharmacological strategies to modulate mechanotransduction, alongside biomaterial platforms for localised drug delivery, clinical translation, regulatory considerations and standardised testing ...
Xueying Xu, Ian L. Chin, Richard P. Tan
wiley   +1 more source

Home - About - Disclaimer - Privacy